EnVVeno Capital Expenditures from 2010 to 2025

NVNO Stock  USD 3.46  0.07  1.98%   
EnVVeno Medical Capital Expenditures yearly trend continues to be very stable with very little volatility. Capital Expenditures is likely to drop to about 36.1 K. During the period from 2010 to 2025, EnVVeno Medical Capital Expenditures quarterly data regression pattern had sample variance of 20.5 B and median of  33,000. View All Fundamentals
 
Capital Expenditures  
First Reported
2016-09-30
Previous Quarter
14 K
Current Value
K
Quarterly Volatility
53.1 K
 
Covid
Check EnVVeno Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnVVeno Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 387 K, Interest Expense of 224.9 K or Other Operating Expenses of 30.5 M, as well as many indicators such as Price To Sales Ratio of 262, Dividend Yield of 0.0 or PTB Ratio of 1.29. EnVVeno financial statements analysis is a perfect complement when working with EnVVeno Medical Valuation or Volatility modules.
  
Check out the analysis of EnVVeno Medical Correlation against competitors.

Latest EnVVeno Medical's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of enVVeno Medical Corp over the last few years. Capital Expenditures are funds used by enVVeno Medical Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of EnVVeno Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is EnVVeno Medical's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EnVVeno Medical's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

EnVVeno Capital Expenditures Regression Statistics

Arithmetic Mean96,673
Geometric Mean21,483
Coefficient Of Variation148.15
Mean Deviation114,665
Median33,000
Standard Deviation143,223
Sample Variance20.5B
Range371K
R-Value0.28
Mean Square Error20.3B
R-Squared0.08
Significance0.29
Slope8,418
Total Sum of Squares307.7B

EnVVeno Capital Expenditures History

202536.1 K
202438 K
202333 K
2022115 K
2021367.9 K
2020180.3 K
2019363.9 K

About EnVVeno Medical Financial Statements

EnVVeno Medical investors utilize fundamental indicators, such as Capital Expenditures, to predict how EnVVeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures38 K36.1 K
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out the analysis of EnVVeno Medical Correlation against competitors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.37)
Return On Equity
(0.59)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.